Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents

Chinese Medical Journal

Volumn 123, Issue 7, 2010, Pages 794-799

  Chen, Shao Liang ^a   Xu, Bo ^b   Mintz, Gary ^c   Ye, Fei ^a   Zhang, Jun Jie ^a   Jing, Kan ^a   Sun, Xue Wen ^d   Zhang, Ai Ping ^e   Chen, Jin Guo ^f   Qian, Jun ^g   Kwan Tak, W ^h  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Fuwai Heart Hospital and Cardiovascular Institute   (China)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d Huainan Oriental Hospital   (China)

^e Department of Cardiology   (China)

^f Chuzhou People's Hospital   (China)

^g Maanshan Central Hospital   (China)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

In stent restenosis; Percutaneous coronary intervention; Unprotected left main stenosis

Indexed keywords

ANTICOAGULANT AGENT; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; STENT THROMBOSIS; UNPROTECTED LEFT MAIN STENOSIS;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; STENTS; TREATMENT OUTCOME;

EID: 77950913729     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.07.006     Document Type: Article

References (16)

1. Gao RL, Xu B, Chen JL, Han YL, Li ZQ, Lü SZ, et al. Prognosis of unprotected left main coronary artery stenting and the factors affecting the outcomes in Chinese. Chin Med J 2006; 119: 14-20.
2. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents fro unprotected left main coronary artery disease. J Am Coll Cardiol 2006; 47: 864-870.
3. White AJ, Kedia G, Mirocha JM, Lee MS, Forrester JS, Morales WC, et al. Comaprison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary stenosis. JACC Cardiovasc Interv 2008; 1: 236-245.
4. Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia HM, Polad J, Tsuchida K, et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluation at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol 2006; 47: 1530-1537.
5. Chen SL, Ye F, Zhang JJ, Liu ZZ, Lin S, Zhu ZS, et al. Distal left main coronary bifurcation lesions predict worse outcome in patients undergoing percutaneous implantation of drug-eluting stents: results from the drug-eluting stent for the treatment of left main disease (DISTAL) study. Cardiology 2009; 113: 264-273.
6. Serruys PW, Morice MC, Kappetein P, Colombo A, Holmes DR, Mack MJ, et al; SYNTAX Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360:961-972.
7. Ralf L, Ioakim S, Janine K, Andreas ZM, Volker S, Stephan F. Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome. J Interven Cardiol 2009; 22: 311-319.
8. Gyöngyösi M, Christ G, Lang I, Kreiner G, Sochor H, Probst P, et al; AUTAX Investigators. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study. JACC Cardiovasc Interv 2009; 2: 718-727.
9. Sheiban I, Sillano D, Biondi-Zoccai G, Chieffo A, Colombo A, Vecchio S, et al. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents. JACC 2009; 54: 1131-1136.
10. Chen SL, Patarca R. Perspectives on stenting of coronary bifurcation lesions. Indian Heart J 2008; 60: 615-624.
11. Klein LW. The bifurcation lesion: more evidence that a new lesion classification system should be widely adopted. Catheter Cardiovasc Interv 2002; 55: 434-435.
12. Mauri L, Hsieh WH, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029.
13. Ellis S, Tamai H, Nobuyoshi M, Kosuga K, Colombo A, Holmea DR, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation 1997; 96:3867-3872.
14. Park SJ, Park SW, Hong MK, Cheong SS, Lee CW, Kim JJ, et al. Stenting of unprotected left main coronary stenoses: immediate and late outcomes. J Am Coll Cardiol 1998; 31: 37-42.
15. Lee RJ, Shih KN, Lee SH, Shyu KG, Chiu CZ, Lin SC, et al. Predictors of long-term outcomes in patients after elective stent implantation for unprotected left main coronary artery disease. Heart Vessels 2007; 22: 99-103.
16. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (drug eluting stent for left main) registry. J Am Coll Cardiol 2008; 51: 2212-2219.